Ziyuan Lu

718 total citations
19 papers, 536 citations indexed

About

Ziyuan Lu is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Ziyuan Lu has authored 19 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 6 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Ziyuan Lu's work include Chronic Myeloid Leukemia Treatments (7 papers), Acute Myeloid Leukemia Research (6 papers) and Acute Lymphoblastic Leukemia research (3 papers). Ziyuan Lu is often cited by papers focused on Chronic Myeloid Leukemia Treatments (7 papers), Acute Myeloid Leukemia Research (6 papers) and Acute Lymphoblastic Leukemia research (3 papers). Ziyuan Lu collaborates with scholars based in China, Germany and United States. Ziyuan Lu's co-authors include Wancheng Chen, Jiaochan Han, Lili Yu, Zenghui Liu, Yang Xiao, Hongbo Li, Yukai Huang, Yanli Li, Chenyan Shi and Fengqi Duan and has published in prestigious journals such as Blood, Scientific Reports and Gene.

In The Last Decade

Ziyuan Lu

18 papers receiving 531 citations

Peers

Ziyuan Lu
Ziyuan Lu
Citations per year, relative to Ziyuan Lu Ziyuan Lu (= 1×) peers Baoquan Song

Countries citing papers authored by Ziyuan Lu

Since Specialization
Citations

This map shows the geographic impact of Ziyuan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziyuan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziyuan Lu more than expected).

Fields of papers citing papers by Ziyuan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziyuan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziyuan Lu. The network helps show where Ziyuan Lu may publish in the future.

Co-authorship network of co-authors of Ziyuan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Ziyuan Lu. A scholar is included among the top collaborators of Ziyuan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziyuan Lu. Ziyuan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Wang, Tao, Xiaodong Zhang, Yan Liu, et al.. (2023). GaN-on-Si micro resonant-cavity light-emitting diodes with dielectric and metal mirrors. Optical Materials. 143. 114096–114096. 4 indexed citations
3.
Liu, Zenghui, Lixuan Chen, Yu Zhan, et al.. (2023). Salidroside affects the Th17/Treg cell balance in aplastic anemia via the STAT3/HIF-1α/RORγt pathway. Redox Report. 28(1). 2225868–2225868. 13 indexed citations
4.
Lu, Ziyuan, et al.. (2023). A controllable IPv6 address generation based on conditional variational autoencoder. 78–81. 1 indexed citations
5.
Lu, Ziyuan, et al.. (2022). Digital twin model of gas turbine and its application in warning of performance fault. Chinese Journal of Aeronautics. 36(3). 449–470. 56 indexed citations
7.
He, Bailin, Qiang Wang, Xiaoli Liu, et al.. (2020). A novel HDAC inhibitor chidamide combined with imatinib synergistically targets tyrosine kinase inhibitor resistant chronic myeloid leukemia cells. Biomedicine & Pharmacotherapy. 129. 110390–110390. 18 indexed citations
9.
Lu, Ziyuan, et al.. (2018). Inhibition of Siah2 Ubiquitin Ligase by Vitamin K3 Attenuates Chronic Myeloid Leukemia Chemo-Resistance in Hypoxic Microenvironment. Medical Science Monitor. 24. 727–735. 16 indexed citations
10.
11.
Lu, Ziyuan, et al.. (2017). Inhibition of autophagy enhances the selective anti-cancer activity of tigecycline to overcome drug resistance in the treatment of chronic myeloid leukemia. Journal of Experimental & Clinical Cancer Research. 36(1). 43–43. 42 indexed citations
12.
Lu, Ziyuan, Na Xu, Xuan Zhou, et al.. (2017). Therapeutic immune monitoring of CD4+CD25+ T cells in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. Oncology Letters. 14(2). 1363–1372. 12 indexed citations
13.
Xu, Na, Yuling Li, Xuan Li, et al.. (2016). Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia. Journal of Hematology & Oncology. 9(1). 40–40. 17 indexed citations
14.
Chen, Wancheng, Yukai Huang, Jiaochan Han, et al.. (2016). Immunomodulatory effects of mesenchymal stromal cells-derived exosome. Immunologic Research. 64(4). 831–840. 276 indexed citations
15.
Xu, Na, Yuling Li, Xuan Zhou, et al.. (2015). CDKN2 Gene Deletion as Poor Prognosis Predictor Involved in the Progression of Adult B-Lineage Acute Lymphoblastic Leukemia Patients. Journal of Cancer. 6(11). 1114–1120. 23 indexed citations
16.
Chen, Wancheng, et al.. (2015). TNF-α −308 G>A polymorphism and risk of bone marrow failure syndrome: A meta-analysis. Gene. 565(1). 1–8. 4 indexed citations
17.
Xu, Na, Xuan Zhou, Lin Li, et al.. (2015). Prognostic Significance of Monosomal Karyotype in Adult Patients With Acute Myeloid Leukemia Treated With Risk-Adapted Protocols. Clinical Lymphoma Myeloma & Leukemia. 15(12). 790–796. 2 indexed citations
18.
Xiao, Yang, Jiayin Song, Zujun Jiang, et al.. (2014). Risk-Factor Analysis of Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation. International Journal of Medical Sciences. 11(6). 652–657. 28 indexed citations
19.
Wang, Liqing, et al.. (2011). [Dynamic of phytoplankton abundance and the relationship with environmental factors in Dianshan Lake, Shanghai].. PubMed. 32(10). 2868–74. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026